Please use this identifier to cite or link to this item: http://localhost:8081/jspui/handle/123456789/21239
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMeena, Alok-
dc.date.accessioned2026-06-16T11:09:09Z-
dc.date.available2026-06-16T11:09:09Z-
dc.date.issued2021-06-
dc.identifier.urihttp://localhost:8081/jspui/handle/123456789/21239-
dc.guideRohatgi,Somaen_US
dc.description.abstractCandida is an opportunistic fungal pathogen and a leading cause of the predominant fungal disease candidiasis, especially among the immunocompromised and those hospitalized with serious underlying diseases. Due to frequent use of antifungals, Candida species have developed resistance against the different classes of drugs available. So there is a need to investigate some alternative immune based therapies that would involve inducing the production of host antifungal molecules against putative Candida antigens. In my project work, I have chosen the SAP protein which was localised to the cell wall of Candida parapsilosis during infection. I have expressed the gene coding the candidate protein Secreted Aspartatyl Proteinases in the E. coli, purified and characterized it by molecular cloning and expression techniques. The role of protein would be investigated in protection against systemic candidiasis when used as a vaccine candidate.en_US
dc.language.isoenen_US
dc.publisherIIT Roorkeeen_US
dc.titleExpression and purification of a putative vaccine candidate from Candida parapsilosisen_US
dc.typeDissertationsen_US
Appears in Collections:MASTERS' THESES (Bio.)

Files in This Item:
File Description SizeFormat 
19610003_ALOK MEENA.pdf1.44 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.